Cavos BiotechCavos Biotech
Cavos Biotech

Cavos Biotech

Genomic and data science company developing novel drugs based on natural resistance mechanisms.

2021Inactive9

About

Cavos Biotech is an emerging genomic and data science company focused on discovering and developing novel therapeutics. They leverage a multi-level genomic algorithm to uncover the genetic basis of extraordinary cancer resistance, aiming to create new drugs for various diseases.

Technology stack

detected 2026-05-26
Est. monthly stack spend~$60/mo
Emailnone
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Cavos Biotech do?

Cavos Biotech is an emerging genomic and data science company focused on discovering and developing novel therapeutics. They leverage a multi-level genomic algorithm to uncover the genetic basis of extraordinary cancer resistance, aiming to create new drugs for various diseases.

How much funding has Cavos Biotech raised?

Cavos Biotech has raised a total of $10M in funding. The most recent round on record is Seed.

Where is Cavos Biotech headquartered?

Cavos Biotech is headquartered in Cambridge, United States.

When was Cavos Biotech founded?

Cavos Biotech was founded in 2021.

What industry does Cavos Biotech operate in?

Cavos Biotech operates in Life Sciences, Biotech, Genomics, Drug Discovery, HealthTech, AI-Driven Drug Discovery.

How many employees does Cavos Biotech have?

Cavos Biotech has approximately 9 people on record.

What is Cavos Biotech's current status?

Cavos Biotech's current operating status is: Inactive.